NYSE:MMS - MAXIMUS Stock Price, Price Target & More

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

MAXIMUS announced a quarterly dividend on Thursday, July 12th. Investors of record on Wednesday, August 15th will be given a dividend of $0.045 per share on Friday, August 31st. This represents a $0.18 annualized dividend and a dividend yield of 0.28%. The ex-dividend date of this dividend is Tuesday, August 14th. View MAXIMUS's Dividend History.

MAXIMUS declared that its board has approved a share repurchase program on Monday, June 25th 2018, which permits the company to repurchase $200,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to repurchase up to 4.9% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

MAXIMUS, Inc. (NYSE:MMS) released its quarterly earnings results on Thursday, May, 10th. The health services provider reported $0.82 EPS for the quarter, missing the Zacks' consensus estimate of $0.84 by $0.02. The health services provider had revenue of $612.79 million for the quarter, compared to the consensus estimate of $617.97 million. MAXIMUS had a return on equity of 21.67% and a net margin of 9.15%. The business's quarterly revenue was down 1.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.80 EPS. View MAXIMUS's Earnings History.

MAXIMUS issued an update on its FY18 earnings guidance on Thursday, May, 10th. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

3 brokers have issued 1-year price targets for MAXIMUS's stock. Their predictions range from $64.00 to $81.00. On average, they anticipate MAXIMUS's share price to reach $69.50 in the next twelve months. This suggests a possible upside of 7.9% from the stock's current price. View Analyst Ratings for MAXIMUS.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to MAXIMUS include Total System Services (TSS), CoStar Group (CSGP), Worldpay (WP), Msci (MSCI), Mercadolibre (MELI), Broadridge Financial Solutions (BR), Alliance Data Systems (ADS), Akamai Technologies (AKAM), Zillow Group Inc Class A (ZG), Zillow Group Inc Class C (Z), CIELO S A/S (CIOXY), Nielsen (NLSN), GrubHub (GRUB), The Western Union (WU) and CDK Global (CDK).

News stories about MMS stock have been trending somewhat positive this week, Accern reports. The research firm identifies positive and negative press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. MAXIMUS earned a daily sentiment score of 0.05 on Accern's scale. They also gave media coverage about the health services provider an impact score of 45.47 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

MAXIMUS's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.55%), Handelsbanken Fonder AB (0.48%), West Coast Financial LLC (0.14%), Contravisory Investment Management Inc. (0.11%), Clinton Group Inc. (0.08%) and Bank of Montreal Can (0.06%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

MMS stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Riverbridge Partners LLC, Clinton Group Inc., Bank of Montreal Can, West Coast Financial LLC and Contravisory Investment Management Inc.. Company insiders that have sold MAXIMUS company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

MMS stock was purchased by a variety of institutional investors in the last quarter, including Xact Kapitalforvaltning AB and Cim LLC. Company insiders that have bought MAXIMUS stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for MAXIMUS.

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MMS stock can currently be purchased for approximately $64.43.

MAXIMUS has a market capitalization of $4.21 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. MAXIMUS employs 20,400 workers across the globe.

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]